Prevention Activities

One of the primary areas of work for the HRSA RCORP Implementation award involves completing key tasks in the area of opioid use prevention. The six key prevention related tasks are listed below. Clicking on the activity in each box will give more information about how COP-RCORP undertook implementing that activity and provide a link to that activity’s page.

Develop, implement, and assess intervention models that leverage opioid overdose reversal and increased naloxone availability as a bridge to treatment and ensure that rural communities have sufficient access to naloxone.

The Ohio counties that make up the COP-RCORP communities approached increasing access to naloxone individually, working with their local consortia to create PSA’s, distribute naloxone, and working with treatment provider agencies. The Prevention CA1: Naloxone webpage describe this process and includes slides and video to describe the activities in each community.

Provide and assess the impact of culturally and linguistically appropriate education to improve family members', caregivers', and the public's understanding of evidence-based treatments and prevention strategies for SUD/OUD and to eliminate stigma associated with the disease.

The COP-RCORP Master Consortium met in November 2019 and decided that Prevention CA 2 was too much to handle all at once. Instead, consortium members decided to break this activity into two parts: education about the CLAS standards and efforts to eliminate stigma. Each of these components of CA2 have a separate page.

CLAS education was addressed by a subgroup of members of the master consortium forming a CLAS workgroup from March to June of 2020, more information about which can be found here.

Stigma was address later in 2020. More information about this is coming soon.

Increase the number of providers who regularly use a Prescription Drug Monitoring Program--OARRS (including prescribers and pharmacists).

More information coming soon.

Provide training and other professional development opportunities to increase the number of providers, including physicians, behavioral health providers, advanced practice nurses, pharmacists, and other health and social service professionals who are able to identify and treat SUD/OUD.

More information about this is coming soon.

Identify and screen individuals who are at risk of SUD/OUD and make available prevention, harm reduction, early intervention services, referral to treatment and other supportive services to minimize the potential for the development of SUD/OUD.

COP-RCORP master consortium members decided to take a hybrid approach to identifying and screening individuals at risk of SUD/OUD by working somewhat independently, but also convening a workgroup to check each other’s progress and share ideas. More information can be found on the Prevention CA4 page: Identifying and Screening.

Track, screen, prevent, and refer to treatment patients with SUD/OUD who have infectious complications, including HIV, viral hepatitis, and endocarditis, particularly among PWID.

More information about this is coming soon.